The Patent Finder

RNL Bio Co., Ltd.

Also on record
Records under this name other than the patents RNL Bio Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Showing 1 to 6 of 6 · Back to RNL Bio Co., Ltd.

PatentTitleStatus Expires Confidence
US 7,807,461Multipotent stem cells derived from human adipose tissue and cellular therapeutic agents comprising the same
Term ended
Term ended Jun 25, 2026 · From the USPTO record
Term endedTerm ended Jun 25, 2026From the USPTO record
US 8,911,802Composition for increasing milk production containing Artemisia capillaris
Lapsed on the fee record
Ended Dec 16, 2022 · From the USPTO record
Lapsed on the fee recordEnded Dec 16, 2022From the USPTO record
US 8,808,682Method for inducing migration of adipose-derived adult stem cells
Lapsed on the fee record
Ended Aug 19, 2022 · From the USPTO record
Lapsed on the fee recordEnded Aug 19, 2022From the USPTO record
US 7,687,062Method for diagnosing colon cancer
Lapsed on the fee record
Ended Mar 30, 2022 · From the USPTO record
Lapsed on the fee recordEnded Mar 30, 2022From the USPTO record
US 8,470,378Anti-influenza viral composition containing bark or stem extract of Alnus japonica
Lapsed on the fee record
Ended Jun 25, 2021 · From the USPTO record
Lapsed on the fee recordEnded Jun 25, 2021From the USPTO record
US 9,211,306Cellular therapeutic agent for incontinence or urine comprising stem cells originated from decidua or adipose
Lapsed on the fee record
Ended Dec 15, 2019 · From the USPTO record
Lapsed on the fee recordEnded Dec 15, 2019From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited